Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02KBE
|
||||
Former ID |
DIB002589
|
||||
Drug Name |
Ad-OC-hsvTK/valacyclovir
|
||||
Synonyms |
Ad-OC-hsvTK; Gene therapy (prostate cancer), Winship Cancer Institute; Adenovirus osteocalcin-promoter-driven HSV thymidine Kinase, Winship Cancer Institute; Ad-OC-hsvTK/valacyclovir, Winship Cancer Institute
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 1 | [546377] | ||
Company |
Winship Cancer Institute
|
||||
Target and Pathway | |||||
Target(s) | Thymidine kinase | Target Info | Inhibitor | [526573] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.